CRIS Current Research Information System

DAJTI, ELTON
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 6.838
NA - Nord America 4.414
EU - Europa 2.894
AF - Africa 397
SA - Sud America 347
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 1
Totale 14.898
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.317
VN - Vietnam 1.977
SG - Singapore 1.743
CN - Cina 1.663
IT - Italia 977
HK - Hong Kong 455
DE - Germania 356
KR - Corea 282
GB - Regno Unito 280
BR - Brasile 256
SE - Svezia 256
IN - India 246
NL - Olanda 205
FR - Francia 159
JP - Giappone 133
IE - Irlanda 119
FI - Finlandia 101
CI - Costa d'Avorio 99
ZA - Sudafrica 97
RU - Federazione Russa 87
SC - Seychelles 77
CH - Svizzera 64
ES - Italia 53
ID - Indonesia 53
CA - Canada 48
BG - Bulgaria 44
PH - Filippine 44
TG - Togo 42
BD - Bangladesh 38
AT - Austria 36
NG - Nigeria 36
TR - Turchia 36
TH - Thailandia 35
UA - Ucraina 31
AR - Argentina 28
MX - Messico 27
PL - Polonia 25
PK - Pakistan 23
BE - Belgio 22
EC - Ecuador 22
JO - Giordania 20
TW - Taiwan 18
IQ - Iraq 17
EG - Egitto 12
VE - Venezuela 11
AL - Albania 10
CO - Colombia 10
EE - Estonia 10
LT - Lituania 9
SA - Arabia Saudita 9
CL - Cile 8
GR - Grecia 8
KE - Kenya 8
AU - Australia 7
CR - Costa Rica 7
PT - Portogallo 7
HR - Croazia 6
IR - Iran 6
CZ - Repubblica Ceca 5
RS - Serbia 5
UZ - Uzbekistan 5
AE - Emirati Arabi Uniti 4
AZ - Azerbaigian 4
DO - Repubblica Dominicana 4
KZ - Kazakistan 4
LB - Libano 4
MA - Marocco 4
MK - Macedonia 4
PE - Perù 4
PY - Paraguay 4
BO - Bolivia 3
MY - Malesia 3
TN - Tunisia 3
AO - Angola 2
BB - Barbados 2
CM - Camerun 2
DZ - Algeria 2
ET - Etiopia 2
GA - Gabon 2
GH - Ghana 2
HN - Honduras 2
HU - Ungheria 2
IL - Israele 2
JM - Giamaica 2
KG - Kirghizistan 2
LV - Lettonia 2
MM - Myanmar 2
MT - Malta 2
NP - Nepal 2
OM - Oman 2
RO - Romania 2
SN - Senegal 2
BF - Burkina Faso 1
BS - Bahamas 1
CY - Cipro 1
DK - Danimarca 1
GI - Gibilterra 1
GN - Guinea 1
IS - Islanda 1
KW - Kuwait 1
Totale 14.881
Salva come PNG Salva come JPEG
Città #
Singapore 1.266
Ashburn 577
Hefei 569
Ho Chi Minh City 521
Hanoi 445
Fairfield 435
Hong Kong 405
San Jose 383
Bologna 266
Seoul 256
Chandler 253
Southend 185
Beijing 155
Dallas 150
Santa Clara 149
New York 143
Los Angeles 137
Dublin 117
Abidjan 99
Tokyo 99
Boardman 95
Council Bluffs 94
Da Nang 93
Seattle 88
Milan 86
Princeton 82
Lauterbourg 80
Houston 75
Haiphong 72
Johannesburg 72
Wilmington 69
Rome 68
Cambridge 66
Woodbridge 66
Munich 64
Bern 54
Bengaluru 53
Helsinki 53
Frankfurt am Main 52
São Paulo 46
Dong Ket 44
Buffalo 42
Lomé 42
Sofia 42
Turin 42
Redondo Beach 40
Redmond 36
Amsterdam 35
Abeokuta 33
Bremen 31
Guangzhou 31
Barcelona 29
Florence 29
Shanghai 28
Ann Arbor 27
Boydton 27
Berlin 26
Biên Hòa 26
Hải Dương 25
Turku 25
Bến Tre 24
Chicago 23
Des Moines 22
Nanjing 22
Orem 22
Brooklyn 21
Lappeenranta 21
London 21
Amman 20
Brussels 20
Bắc Ninh 20
Jakarta 20
Paris 20
Phoenix 20
San Diego 20
San Francisco 20
Tongling 19
Vienna 19
Vũng Tàu 19
Warsaw 19
Hyderabad 18
Montreal 18
Washington 18
Tianjin 17
Hangzhou 16
Quận Ba 16
Wuhan 16
Chennai 15
Falkenstein 15
Nha Trang 15
Rimini 15
The Dalles 15
Thái Bình 15
Atlanta 14
Bangkok 14
Forlì 14
Medford 14
Stockholm 14
Can Tho 13
Denver 13
Totale 9.415
Salva come PNG Salva come JPEG
Nome #
Monofocal hepatocellular carcinoma: How much does size matter? 285
A combined Baveno VII and spleen stiffness algorithm to improve the non-invasive diagnosis of clinically significant portal hypertension in patients with compensated advanced chronic liver disease 254
A nomogram-based prognostic model for advanced hepatocellular carcinoma patients treated with sorafenib: A multicenter study 239
Pattern of macrovascular invasion in hepatocellular carcinoma 233
Recalibrating survival prediction among patients receiving trans‐arterial chemoembolization for hepatocellular carcinoma 233
Assessment of liver stiffness measurement and ultrasound findings change during inotuzumab ozogamicin cycles for relapsed or refractory acute lymphoblastic leukemia 227
Comparison of prognostic models in advanced hepatocellular carcinoma patients undergoing Sorafenib: A multicenter study 222
Landscape of alcohol-related hepatocellular carcinoma in the last 15 years highlights the need to expand surveillance programs 220
Clinical impact of sarcopenia assessment in patients with hepatocellular carcinoma undergoing treatments 219
Sarcopenia evaluated by EASL/AASLD computed tomography-based criteria predicts mortality in patients with cirrhosis: A systematic review and meta-analysis 211
Size and location of spontaneous portosystemic shunts predict the risk of decompensation in cirrhotic patients 210
Clinical impact of sarcopenia assessment in patients with liver cirrhosis 209
Pre-transplant psoas muscle density as a ready-to-use and low-cost predictor of patient survival after liver transplant 206
The changing scenario of hepatocellular carcinoma in Italy: an update 204
Kawasaki disease, multisystem inflammatory syndrome in children, and adenoviral infection: a scoring system to guide differential diagnosis 198
Sarcopenia predicts ascitic decompensation and mortality independently of portal hypertension status in patients with advanced chronic liver disease outside the liver transplantation setting 191
A SPLEEN STIFFNESS MEASUREMENT-BASED MODEL FOR THE RECOGNITION OF HIGH RISK VARICES: BAVENO VI CRITERIA AND BEYOND 191
Material deprivation affects the management and clinical outcome of hepatocellular carcinoma in a high-resource environment 191
Utility of Doppler-Ultrasound and Liver Elastography in the Evaluation of Patients with Suspected Pregnancy-Related Liver Disease 190
Characteristics and survival of patients with primary biliary cholangitis and hepatocellular carcinoma 188
“Are the Expanded Baveno VI Criteria really safe to screen compensated cirrhotic patients for high-risk varices?” 187
Long-term outcome and risk stratification in compensated advanced chronic liver disease after HCV-cure 186
The non‐invasive evaluation of liver involvement in patients with cystic fibrosis: A prospective study 183
Systematic review with meta-analysis: Diagnostic performance of faecal calprotectin in distinguishing inflammatory bowel disease from irritable bowel syndrome in adults 176
Combination of fecal calprotectin and initial coronary dimensions to predict coronary artery lesions persistence in Kawasaki disease 175
Standard Bismuth Quadruple Therapy versus Concomitant Therapy for the First-Line Treatment of Helicobacter pylori Infection: A Systematic Review and Meta-Analysis of Randomized Controlled Trials 175
Advances in Endo-Hepatology: The Role of Endoscopic Ultrasound in the Management of Portal Hypertension 175
Survival After Transarterial Radioembolization in Patients with Unresectable Intrahepatic Cholangiocarcinoma: An Updated Meta-analysis and Meta-regression 174
A spleen stiffness measurement-based model for the recognition of high risk varices: Baveno VI criteria and beyond 174
Spleen stiffness decrease as mirror of portal hypertension changes after successful interferon-free therapy in chronic-HCV patients 174
Adherence to European Society of Gastrointestinal Endoscopy Quality Performance Measures for Upper and Lower Gastrointestinal Endoscopy: A Nationwide Survey From the Italian Society of Digestive Endoscopy 171
Segmental Distribution of Hepatocellular Carcinoma in Cirrhotic Livers 169
Spleen stiffness mirrors changes in portal hypertension after successful interferon-free therapy in chronic-hepatitis C virus patients 167
Role of imaging techniques in liver veno-occlusive disease diagnosis: recent advances and literature review 166
Non-invasive tests for the prediction of post-hepatectomy liver failure in the elderly 166
Autoimmune Atrophic Gastritis: A Clinical Review 158
Spleen Stiffness Measurements Predict the Risk of Hepatic Decompensation after Direct-Acting Antivirals in HCV Cirrhotic Patients 158
Can Liver Ultrasound Elastography Predict the Risk of Hepatocellular Carcinoma Recurrence After Radiofrequency Ablation? A Systematic Review and Meta-Analysis 154
Performance of spleen stiffness measurement to rule out high-risk varices in patients with porto-sinusoidal vascular disorder 153
Hierarchically Positioning Laparoscopic Microwave Ablation in the Therapeutic Span of Early Hepatocellular Carcinoma: A Real-Life Comparative Analysis 153
The Role of Microbiota in Upper Gastrointestinal Cancers 150
Approaches to the Diagnosis of Portal Hypertension: Non-Invasive or Invasive Tests? 150
Sarcopenia predict complications after hepatic resection for primary hepatocellular carcinoma (HCC) in patients with advanced chronic liver disease (ACLD) and clinically significant portal hypertension (CSPH) 149
Indocyanine green retention test predict the risk of portal hypertension-related events after direct-acting antiviral therapy in compensated advanced chronic liver disease patients 149
Biliary Diseases from the Microbiome Perspective: How Microorganisms Could Change the Approach to Benign and Malignant Diseases 149
Liver and Spleen Stiffness Measurements for Assessment of Portal Hypertension Severity in Patients with Budd Chiari Syndrome 146
Liver Measurement Stiffness Can Predict Chemotherapy-related Liver Injury and Complications after Surgery for Liver Metastases 145
Is Ultrasound Elastography Useful in Predicting Clinically Relevant Pancreatic Fistula After Pancreatic Resection?: A Systematic Review and Meta-analysis 145
Spleen stiffness measurement predicts the development of primary hepatocellular carcinoma better than hepatic venous pressure gradient 145
Non-invasive diagnosis of clinically significant portal hypertension and treatment with non-selective beta-blockers: a new paradigm 142
Epidemiological, diagnostic, therapeutic and prognostic impact of hepatitis B and D virus infection on hepatocellular carcinoma: A review of the literature 141
The interplay between sarcopenia and portal hypertension predicts ascites and mortality in cirrhosis: Sarcopenia predicts ascites and death in cirrhotic patients 140
A spleen stiffness measurement-based model for recognition of high risk varices: Baveno VI criteria and beyond 139
Osteosarcopenia in NAFLD/MAFLD: An Underappreciated Clinical Problem in Chronic Liver Disease 138
Corrigendum: Adherence to European society of gastrointestinal endoscopy quality performance measures for upper and lower gastrointestinal endoscopy: a nationwide survey from the Italian society of digestive endoscopy 137
Clinical presentation of celiac disease and diagnosis accuracy in a single-center european pediatric cohort over 10 years 135
HEPATIC DECOMPENSATION RISK IS REDUCED, BUT NOT ELIMINATED AFTER DIRECT-ACTING ANTIVIRALS: THE ROLE OF SPLEEN STIFFNESS MEASUREMENT 134
Predictive factors for hepatocellular carcinoma recurrence after curative treatments 134
New practice guidelines on risk stratification and management of portal hypertension: towards a personalized multidisciplinary approach 132
Adherence to international guidelines for the management of Helicobacter pylori infection among gastroenterologists and gastroenterology fellows in Italy: A Survey of the Italian Federation of Digestive Diseases - FISMAD 131
Non-invasive tests for the prediction of primary hepatocellular carcinoma 130
Idiopathic chronic intestinal pseudo-obstruction syndrome is strongly associated with low serum levels of vitamin D 130
Porto-sinusoidal vascular disorder in surgical candidates for liver metastases: prevalence, non-invasive diagnosis, and burden on surgical outcomes 129
Gut microbiota signatures and clinical manifestations in celiac disease children at onset: a pilot study 126
Spleen stiffness measurement for assessing the response to β-blockers therapy for high-risk esophageal varices patients- UEG Week 2020 Poster Presentations 121
New insights on portal hypertension's screening in people with cystic fibrosis 120
Prediction of posthepatectomy liver failure: Role of SSM and LSPS 119
Validation of a standardized CT protocol for the evaluation of varices and porto-systemic shunts in cirrhotic patients 119
null 115
Diagnostic Approach to Elevated Liver Function Tests during Pregnancy: A Pragmatic Narrative Review 112
Surveillance for hepatocellular carcinoma with a 3-months interval in "extremely high-risk" patients does not further improve survival 109
Spleen stiffness measurement for assessing the response to β-blockers therapy for high-risk esophageal varices patients 109
Management of Helicobacter pylori infection: Guidelines of the Italian Society of Gastroenterology (SIGE) and the Italian Society of Digestive Endoscopy (SIED) 108
Risk of hepatocellular carcinoma after HCV eradication: Determining the role of portal hypertension by measuring spleen stiffness 105
A combined model based on spleen stiffness measurement and Baveno VI criteria to rule out high-risk varices in advanced chronic liver disease 104
The role of liver and spleen elastography in advanced chronic liver disease 103
Reply to: Triple-phase CT scan for disease progression prediction in cirrhosis: A valid repurpose? 100
Antibiotic prophylaxis in patients with cirrhosis: Current evidence for clinical practice 98
Sarcopenia Predicts Major Complications after Resection for Primary Hepatocellular Carcinoma in Compensated Cirrhosis 98
Ruolo e significato clinico dei metodi non invasivi nella valutazione dell’ipertensione portale nel paziente affetto da epatopatia cronica 96
Minimally invasive hepatectomy vs. thermoablation for single small (≤3 cm) hepatocellular carcinoma: A weighted real-life national comparison 95
Post-treatment LSM rather than change during treatment predicts decompensation in patients with cACLD after HCV cure 95
Hepatic encephalopathy and MELD-Na predict treatment benefit in autoimmune hepatitis-related decompensated cirrhosis 94
Validation of a standardized CT protocol for the evaluation of varices and porto-systemic shunts in cirrhotic patients 92
Characteristics and Outcomes of Hepatocellular Carcinoma in Patients with Autoimmune Hepatitis 91
Liver Stiffness Measurement Allows Early Diagnosis of Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome in Adult Patients Who Undergo Hematopoietic Stem Cell Transplantation: Results from a Monocentric Prospective Study 91
Trial sequential analysis of EUS-guided gallbladder drainage versus percutaneous cholecystostomy in patients with acute cholecystitis 90
Sarcopenia Predicts Major Complications after Resection for Primary Hepatocellular Carcinoma in Compensated Cirrhosis 90
Non-invasive diagnosis of clinically significant portal hypertension and treatment with non-selective beta-blockers: a new paradigm 86
Covid-19 in a young liver transplant recipient: Caution for drug-drug interactions 84
In-hospital Mortality in Patients with Lower Gastrointestinal Bleeding: Development and Validation of a Prediction Score 84
Determinants of outcomes of transmural EUS-guided gallbladder drainage: systematic review with proportion meta-analysis and meta-regression 83
null 83
Diagnostic accuracy of FibroScan-AST (FAST) score for the non-invasive identification of patients with fibrotic non-alcoholic steatohepatitis: a systematic review and meta-analysis 79
Size and location of spontaneous portosystemic shunts predict the risk of decompensation in cirrhotic patients 77
Absence of Viral Replication Is Associated With Improved Outcome in Anti-HCV-Positive Patients With Hepatocellular Carcinoma 72
Incidence and clinical significance of recompensation after HCV-cure 67
Spleen stiffness measurement by vibration-controlled transient elastography at 100 Hz for non-invasive predicted diagnosis of clinically significant portal hypertension in patients with compensated advanced chronic liver disease: a modelling study 65
Efficacy and safety of endoscopic ultrasound-guided hepaticogastrostomy: a meta-regression analysis 64
Functional Foods and Nutraceuticals in Irritable Bowel Syndrome 64
Totale 14.443
Salva come PNG Salva come JPEG
Categoria #
all - tutte 42.934
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 42.934
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021186 0 0 0 0 0 0 0 0 0 0 14 172
2021/20221.128 19 14 25 31 80 34 42 69 53 71 550 140
2022/20231.384 76 136 52 160 107 127 60 55 248 45 169 149
2023/2024651 41 94 58 65 58 167 26 33 25 42 22 20
2024/20252.615 104 239 191 188 257 120 225 107 58 283 272 571
2025/20268.438 803 1.001 745 690 643 311 1.414 387 1.619 655 170 0
Totale 15.236